Mesenchymal Stem Cell-Derived Extracellular Vesicles as an Advanced Therapy for Chronic Wounds

Area of Science:

• Regenerative Medicine
• Biotechnology
• Wound Healing Research

Background:

• Chronic wounds pose significant clinical challenges due to complex pathophysiology involving inflammation, hypoxia, and oxidative stress.
• Current treatments often fail to address all underlying mechanisms of chronic wound development.
• Advancing age is a common comorbidity exacerbating chronic wound complexity.

Purpose of the Study:

• To review the therapeutic potential of Mesenchymal Stem Cell-derived Extracellular Vesicles (MSC-EVs) for chronic wound healing.
• To discuss strategies for enhancing MSC-EV efficacy in wound regeneration.
• To summarize the current clinical and preclinical landscape of MSC-EVs in wound care.

Main Methods:

• Literature review of studies on MSC-EVs and chronic wound pathophysiology.
• Analysis of mechanisms by which MSC-EVs modulate inflammation, hypoxia, and oxidative stress.
• Evaluation of preclinical data and ongoing clinical trials for MSC-EV based therapies.

Main Results:

• MSC-EVs demonstrate significant potential to target key pathological processes in chronic wounds.
• Methods exist to modulate MSCs for the production of more potent wound-healing EVs.
• Several clinical trials are investigating the efficacy of EVs for wound healing.

Conclusions:

• MSC-EVs represent a promising cell-free therapeutic strategy for chronic wound management.
• Further research and optimized preclinical studies are crucial for advancing MSC-EVs into widespread clinical practice.
• Targeting chronic inflammation, hypoxia, and oxidative stress with MSC-EVs offers a novel therapeutic avenue.